SCHEDULE: First Eagle Boosts Bio-Rad Stake to 11.4%

First Eagle Investment Management and its Global Fund have reported an 11.4% beneficial ownership stake in Bio-Rad Laboratories Inc.

Summary

• First Eagle Investment Management, LLC and FIRST EAGLE GLOBAL FUND have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in Bio-Rad Laboratories Inc.
• As of June 30, 2025, First Eagle Investment Management, LLC beneficially owns 2,528,321.43 shares of Bio-Rad Laboratories Inc. common stock, representing 11.4% of the class.
• Within this total, FIRST EAGLE GLOBAL FUND is deemed to beneficially own 1,878,739.00 shares, which constitutes 8.5% of the class.
• First Eagle Investment Management, LLC holds sole voting power over 2,326,836.25 shares and sole dispositive power over 2,528,321.43 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership by an institutional investor. It does not contain information that inherently indicates positive or negative sentiment regarding the issuer's operational performance or financial health. The sentiment is neutral as it is a factual reporting of a significant stake.

Future Outlook

NA

Management Comments

• Securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

NA

Stakeholder Impact

• Signals significant institutional investor interest in Bio-Rad Laboratories Inc., which may be viewed positively by other shareholders.
• Indicates that a substantial portion of the company's common stock is held by a large investment management firm on behalf of its clients.

Key Dates

Keywords

Bio-Rad Laboratories, First Eagle Investment Management, FIRST EAGLE GLOBAL FUND, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Healthcare, Life Sciences